By Adam Burroughs and Mark Scott
Cyprium Partners co-founder MIchael Conaton discusses where he thinks investors will look when they begin scrutinizing deals as the economy starts to recover and the rise of EBIDTA before COVID.
June 3, 2020
Business owners who can keep their companies afloat during a global pandemic will be quite attractive to investors when the economy begins to grow again, says R. Louis Schneeberger, executive chairman at Proformex.
May 21, 2020
Oswald’s Bob Klonk: Supply Chain Risk Will Be A Critical Negotiating Point For Post-Pandemic Dealmaking
Health experts have stressed repeatedly that a COVID-19 vaccine is most likely at least a year away, a reality that will be on the minds of dealmakers at every turn, says Oswald Cos. CEO Chairman and CEO Robert J. Klonk.
May 7, 2020
Tucker Ellis’s Brian M. O’Neill: The Future Of Dealmaking Post-Pandemic Will Need Time To Take Shape
As Ohio seeks to reopen its economy in the coming weeks, a significant number of businesses will face a daunting challenge to simply reopen their doors to customers, says Brian M. O’Neill, a partner at Tucker Ellis.
April 10, 2020
As the unprecedented shutdown of American business continues, Smart Business magazine sat down with three top local dealmakers to discuss how the coronavirus pandemic has impacted their clients and their dealmaking activity. Dealmakers has some excerpts from the upcoming magazine article.
March 19, 2020
Cyprium Partners’ John Sinnenberg: Noncontrol Capital Market Provides A Wide Range Of Dealmaking Options
Cyprium Partners’ John Sinnenberg works with business owners who need capital but don't want to give up control. It’s a unique market that leads to a variety of deal types.
February 20, 2020
As the Chinese government continues to grapple with the impact of the coronavirus within its borders, the disease’s impact on the U.S. economy has been negligible.
February 14, 2020
The cannabis space is an interesting investment opportunity that comes with a variety of risks, but as Ohio’s medical marijuana cultivators and dispensaries slowly gain ground, the nascent industry should pick up speed in 2020.
January 2, 2020
We spoke with Copper Run Capital's Matt Roberts, ErieBank’s Wes Gillespie, Carleton McKenna’s Chris McKenna and Folio Photonics’ Steven Santamaria to get their thoughts on what to expect from a dealmaking perspective in 2020.
November 26, 2019
Dealmakers who fail to incorporate IT due diligence into their M&A strategy are taking a big risk, says OPT Solutions Founder Laura Pettit Rusick.
November 12, 2019
BioEnterprise’s Aram Nerpouni: Talent Is Vital To Creating Deal Opportunities In Cleveland’s Health Care Sector
Cool ideas are great. Investors want to see the leadership and the team behind the idea before they invest, says the nonprofit's president and CEO.
September 27, 2019
Tom Zucker of M&A advisory firm EdgePoint Capital talks about the effect interest rates typically have on M&A activity and the continued rise of corporate divestitures in the dealmaking space.
August 22, 2019
The president of the Cleveland Chapter of the Association for Corporate Growth talks about some of the trends affecting dealmaking activity in Northeast Ohio.
June 4, 2019
The real estate investor is realizing healthy returns for investors from its platform that invests in value-add apartments with operating partners.
April 12, 2019
Dealmaking is hot in Northeast Ohio’s biomedical community, with 71 regional companies receiving $294 million in funding in 2018. BioEnterprise’s Aram Nerpouni explains how this dealmaking trend could become the “new normal.”
March 22, 2019
The immigration/investment program that brought more than $250 million to Northeast Ohio to finance real estate projects faces an uncertain future,